| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 ERN2 PRKAA1 ULK2 CDK2 CDK3 AURKB | 3.43e-07 | 363 | 211 | 17 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 ERN2 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 1.33e-06 | 446 | 211 | 18 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ERN1 CDK15 RIPK2 MAST2 TAOK3 PI4KB MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 TEX14 ERN2 ITPKC PIK3R6 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 6.58e-06 | 709 | 211 | 22 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERN1 CDK15 RIPK2 MAST2 TAOK3 PI4KB MAP3K9 ULK4 POLL CAMK2A CAMK2D CAMK2G AAK1 TEX14 PARP14 ERN2 TERT ITPKC PIK3R6 FLAD1 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 6.98e-06 | 938 | 211 | 26 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | ERN1 CDK15 RIPK2 MAST2 TAOK3 PI4KB MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 TEX14 ERN2 ITPKC PIK3R6 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 2.09e-05 | 764 | 211 | 22 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 TEX14 ERN2 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 2.19e-05 | 600 | 211 | 19 | GO:0004672 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | MYO9A RAPGEF5 DENND4B RIC8A DENND5A BCAR3 DOCK6 ARHGAP21 AGAP2 RASA2 ARHGAP10 ARHGEF12 PLEKHG2 ARHGAP35 TBC1D8 RANBP3L WDR41 | 2.95e-05 | 507 | 211 | 17 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | MYO9A RAPGEF5 DENND4B RIC8A DENND5A BCAR3 DOCK6 ARHGAP21 AGAP2 RASA2 ARHGAP10 ARHGEF12 PLEKHG2 ARHGAP35 TBC1D8 RANBP3L WDR41 | 2.95e-05 | 507 | 211 | 17 | GO:0030695 |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 3.08e-04 | 13 | 211 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 3.08e-04 | 13 | 211 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | sodium,bicarbonate:chloride antiporter activity | 3.31e-04 | 3 | 211 | 2 | GO:0140892 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 3.37e-04 | 57 | 211 | 5 | GO:0120013 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | ERCC5 MYO9A RAPGEF5 BIRC6 CFLAR TAOK3 NOD1 DENND4B RIC8A DENND5A BCAR3 DOCK6 MNAT1 ARHGAP21 AGAP2 LILRB4 RASA2 ARHGAP10 ARHGEF12 RICTOR PLEKHG2 ARHGAP35 NLRP3 TBC1D8 PPP1R10 PPP2R5C PIK3R6 RANBP3L WDR41 | 4.74e-04 | 1418 | 211 | 29 | GO:0030234 |
| GeneOntologyMolecularFunction | enzyme activator activity | ERCC5 MYO9A CFLAR NOD1 RIC8A MNAT1 ARHGAP21 AGAP2 RASA2 ARHGAP10 ARHGEF12 RICTOR ARHGAP35 NLRP3 TBC1D8 PPP2R5C RANBP3L | 6.29e-04 | 656 | 211 | 17 | GO:0008047 |
| GeneOntologyMolecularFunction | GTPase activator activity | MYO9A RIC8A ARHGAP21 AGAP2 RASA2 ARHGAP10 ARHGEF12 ARHGAP35 TBC1D8 RANBP3L | 8.01e-04 | 279 | 211 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RAPGEF5 DENND4B RIC8A DENND5A BCAR3 DOCK6 ARHGEF12 PLEKHG2 WDR41 | 8.11e-04 | 231 | 211 | 9 | GO:0005085 |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 1.07e-05 | 5 | 216 | 3 | GO:0005954 | |
| GeneOntologyCellularComponent | nuclear pore inner ring | 3.17e-04 | 3 | 216 | 2 | GO:0044611 | |
| GeneOntologyCellularComponent | phagophore | 3.17e-04 | 3 | 216 | 2 | GO:0061908 | |
| Domain | Leu-rich_rpt | LRRC37A3 LRRC37A2 TSHR LRRC70 IGSF10 NOD1 LRRC37A LRFN5 NLRP13 KERA LRRC8D NLRP3 LRCH3 LRRC20 TLR3 LRRC1 PODN | 1.71e-08 | 271 | 215 | 17 | IPR001611 |
| Domain | - | LRRC37A3 LRRC37A2 TSHR LRRC70 IGSF10 NOD1 LRRC37A LRFN5 ZER1 NLRP13 KERA LRRC8D NLRP3 LRCH3 LRRC20 TLR3 LRRC1 PODN | 3.62e-08 | 321 | 215 | 18 | 3.80.10.10 |
| Domain | L_dom-like | LRRC37A3 LRRC37A2 TSHR LRRC70 IGSF10 NOD1 LRRC37A LRFN5 ZER1 NLRP13 KERA LRRC8D NLRP3 LRCH3 LRRC20 TLR3 LRRC1 PODN | 5.03e-08 | 328 | 215 | 18 | IPR032675 |
| Domain | LRR_TYP | LRRC37A3 LRRC37A2 LRRC70 IGSF10 LRRC37A LRFN5 KERA LRRC8D LRCH3 LRRC20 TLR3 LRRC1 PODN | 1.41e-07 | 177 | 215 | 13 | SM00369 |
| Domain | Leu-rich_rpt_typical-subtyp | LRRC37A3 LRRC37A2 LRRC70 IGSF10 LRRC37A LRFN5 KERA LRRC8D LRCH3 LRRC20 TLR3 LRRC1 PODN | 1.41e-07 | 177 | 215 | 13 | IPR003591 |
| Domain | PROTEIN_KINASE_ST | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 ERN2 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 2.20e-07 | 362 | 215 | 18 | PS00108 |
| Domain | Pkinase | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 ERN2 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 4.67e-07 | 381 | 215 | 18 | PF00069 |
| Domain | LRR_8 | LRRC37A3 LRRC37A2 LRRC70 IGSF10 LRRC37A KERA LRRC8D LRCH3 LRRC20 TLR3 LRRC1 PODN | 7.04e-07 | 171 | 215 | 12 | PF13855 |
| Domain | Ser/Thr_kinase_AS | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 CAMK2A CAMK2D CAMK2G AAK1 ERN2 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 8.82e-07 | 357 | 215 | 17 | IPR008271 |
| Domain | Kinase-like_dom | ERN1 CDK15 RIPK2 MAST2 TAOK3 PI4KB MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 TEX14 ARHGAP35 ERN2 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 1.30e-06 | 542 | 215 | 21 | IPR011009 |
| Domain | LRR_1 | LRRC37A3 LRRC37A2 TSHR LRRC70 LRRC37A LRFN5 KERA LRRC8D LRCH3 LRRC20 TLR3 LRRC1 PODN | 1.61e-06 | 219 | 215 | 13 | PF00560 |
| Domain | ARM-type_fold | INTS1 DNAAF5 DIAPH1 ULK4 UTP20 ZER1 RIC8A MMS19 MYBBP1A IPO8 RICTOR PPP2R5C PELP1 UPF2 NUP188 SYMPK | 2.10e-06 | 339 | 215 | 16 | IPR016024 |
| Domain | Prot_kinase_dom | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 TEX14 ERN2 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 4.08e-06 | 489 | 215 | 19 | IPR000719 |
| Domain | S_TKc | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 CAMK2A CAMK2D CAMK2G AAK1 ERN2 PRKAA1 ULK2 CDK2 CDK3 AURKB | 4.37e-06 | 359 | 215 | 16 | SM00220 |
| Domain | PROTEIN_KINASE_DOM | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 TEX14 ERN2 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 4.58e-06 | 493 | 215 | 19 | PS50011 |
| Domain | CaMKII_AD | 5.97e-06 | 4 | 215 | 3 | PF08332 | |
| Domain | LRRC37AB_C | 5.97e-06 | 4 | 215 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 5.97e-06 | 4 | 215 | 3 | PF14914 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 5.97e-06 | 4 | 215 | 3 | IPR013543 | |
| Domain | LRRC37_N | 5.97e-06 | 4 | 215 | 3 | IPR032754 | |
| Domain | LRRC37 | 5.97e-06 | 4 | 215 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 5.97e-06 | 4 | 215 | 3 | IPR015753 | |
| Domain | PROTEIN_KINASE_ATP | ERN1 CDK15 RIPK2 MAST2 TAOK3 MAP3K9 ULK4 CAMK2A CAMK2D CAMK2G AAK1 ERN2 PRKAA1 IRAK3 ULK2 CDK2 CDK3 AURKB | 6.50e-06 | 459 | 215 | 18 | PS00107 |
| Domain | - | 1.19e-05 | 93 | 215 | 8 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 1.89e-05 | 99 | 215 | 8 | IPR011029 | |
| Domain | ANION_EXCHANGER_2 | 5.09e-05 | 7 | 215 | 3 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 5.09e-05 | 7 | 215 | 3 | PS00219 | |
| Domain | LRR | LRRC37A3 LRRC37A2 LRRC70 LRRC37A LRFN5 KERA LRRC8D TLR3 LRRC1 PODN | 1.16e-04 | 201 | 215 | 10 | PS51450 |
| Domain | - | 1.20e-04 | 9 | 215 | 3 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 1.20e-04 | 9 | 215 | 3 | IPR013769 | |
| Domain | Band_3_cyto | 1.20e-04 | 9 | 215 | 3 | PF07565 | |
| Domain | Nucleoporin_Nup133/Nup155_C | 1.32e-04 | 2 | 215 | 2 | IPR007187 | |
| Domain | Nucleoporin_Nup133/Nup155_N | 1.32e-04 | 2 | 215 | 2 | IPR014908 | |
| Domain | ATG2 | 1.32e-04 | 2 | 215 | 2 | IPR026849 | |
| Domain | Nucleoporin_N | 1.32e-04 | 2 | 215 | 2 | PF08801 | |
| Domain | ATG2_CAD | 1.32e-04 | 2 | 215 | 2 | PF13329 | |
| Domain | Nucleoporin_C | 1.32e-04 | 2 | 215 | 2 | PF03177 | |
| Domain | ATG2_CAD_motif | 1.32e-04 | 2 | 215 | 2 | IPR026885 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.42e-04 | 69 | 215 | 6 | IPR020636 | |
| Domain | LRR_5 | 1.70e-04 | 10 | 215 | 3 | PF13306 | |
| Domain | LRR_5 | 1.70e-04 | 10 | 215 | 3 | IPR026906 | |
| Domain | PTrfase/Anion_transptr | 1.70e-04 | 10 | 215 | 3 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.70e-04 | 10 | 215 | 3 | IPR003020 | |
| Domain | HCO3_cotransp | 1.70e-04 | 10 | 215 | 3 | PF00955 | |
| Domain | HCO3_transpt_C | 1.70e-04 | 10 | 215 | 3 | IPR011531 | |
| Domain | - | DNAAF5 ULK4 UTP20 ZER1 RIC8A MMS19 IPO8 RICTOR PPP2R5C SYMPK | 2.60e-04 | 222 | 215 | 10 | 1.25.10.10 |
| Domain | ARM-like | DNAAF5 ULK4 UTP20 ZER1 RIC8A MMS19 IPO8 RICTOR PPP2R5C PELP1 SYMPK | 3.07e-04 | 270 | 215 | 11 | IPR011989 |
| Domain | KEN_dom | 3.93e-04 | 3 | 215 | 2 | IPR010513 | |
| Domain | PQQ | 3.93e-04 | 3 | 215 | 2 | PF01011 | |
| Domain | Ribonuc_2-5A | 3.93e-04 | 3 | 215 | 2 | PF06479 | |
| Domain | KEN | 3.93e-04 | 3 | 215 | 2 | PS51392 | |
| Domain | - | 3.95e-04 | 13 | 215 | 3 | 3.10.450.50 | |
| Domain | LRR_6 | 4.20e-04 | 55 | 215 | 5 | PF13516 | |
| Domain | PIN_domain-like | 4.99e-04 | 14 | 215 | 3 | IPR029060 | |
| Domain | NTF2-like_dom | 6.18e-04 | 15 | 215 | 3 | IPR032710 | |
| Domain | Coact_PPARg | 7.79e-04 | 4 | 215 | 2 | IPR026784 | |
| Domain | LRRNT | 9.48e-04 | 98 | 215 | 6 | IPR000372 | |
| Domain | LRRNT | 9.48e-04 | 98 | 215 | 6 | SM00013 | |
| Domain | PUG | 1.29e-03 | 5 | 215 | 2 | SM00580 | |
| Domain | Na/HCO3_transpt | 1.29e-03 | 5 | 215 | 2 | IPR003024 | |
| Domain | Autophagy-rel_C | 1.29e-03 | 5 | 215 | 2 | IPR015412 | |
| Domain | ATG_C | 1.29e-03 | 5 | 215 | 2 | PF09333 | |
| Domain | Anion_exchange | 1.29e-03 | 5 | 215 | 2 | IPR001717 | |
| Domain | CH | 1.54e-03 | 73 | 215 | 5 | PS50021 | |
| Domain | CH-domain | 1.73e-03 | 75 | 215 | 5 | IPR001715 | |
| Domain | LNS2 | 1.92e-03 | 6 | 215 | 2 | IPR013209 | |
| Domain | PQQ | 1.92e-03 | 6 | 215 | 2 | SM00564 | |
| Domain | Adcy_conserved_dom | 1.92e-03 | 6 | 215 | 2 | IPR009398 | |
| Domain | PI_transfer | 1.92e-03 | 6 | 215 | 2 | IPR001666 | |
| Domain | LNS2 | 1.92e-03 | 6 | 215 | 2 | SM00775 | |
| Domain | DDHD | 1.92e-03 | 6 | 215 | 2 | PF02862 | |
| Domain | DDHD | 1.92e-03 | 6 | 215 | 2 | PS51043 | |
| Domain | DDHD_dom | 1.92e-03 | 6 | 215 | 2 | IPR004177 | |
| Domain | PUB_domain | 1.92e-03 | 6 | 215 | 2 | IPR018997 | |
| Domain | PQQ_repeat | 1.92e-03 | 6 | 215 | 2 | IPR002372 | |
| Domain | DUF1053 | 1.92e-03 | 6 | 215 | 2 | PF06327 | |
| Domain | LNS2 | 1.92e-03 | 6 | 215 | 2 | PF08235 | |
| Domain | PQQ_beta_propeller_repeat | 1.92e-03 | 6 | 215 | 2 | IPR018391 | |
| Domain | - | 1.92e-03 | 6 | 215 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 1.92e-03 | 6 | 215 | 2 | IPR027295 | |
| Domain | LNS2/PITP | 1.92e-03 | 6 | 215 | 2 | IPR031315 | |
| Domain | DDHD | 1.92e-03 | 6 | 215 | 2 | SM01127 | |
| Domain | HEAT | 2.24e-03 | 48 | 215 | 4 | PF02985 | |
| Domain | NACHT | 2.25e-03 | 23 | 215 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 2.25e-03 | 23 | 215 | 3 | IPR007111 | |
| Domain | Quinoprotein_ADH-like_supfam | 3.22e-03 | 53 | 215 | 4 | IPR011047 | |
| Domain | Rho_GTPase_activation_prot | 3.49e-03 | 88 | 215 | 5 | IPR008936 | |
| Domain | Chorein_N | 3.53e-03 | 8 | 215 | 2 | PF12624 | |
| Domain | AC_N | 3.53e-03 | 8 | 215 | 2 | IPR032628 | |
| Domain | Adcy | 3.53e-03 | 8 | 215 | 2 | IPR030672 | |
| Domain | HATC_C_dom | 3.53e-03 | 8 | 215 | 2 | IPR008906 | |
| Domain | Dimer_Tnp_hAT | 3.53e-03 | 8 | 215 | 2 | PF05699 | |
| Domain | VPS13_N | 3.53e-03 | 8 | 215 | 2 | IPR026854 | |
| Domain | AC_N | 3.53e-03 | 8 | 215 | 2 | PF16214 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A INTS1 ATG2A MAST2 BIRC6 REPIN1 ADCY7 PLEKHM1 FAT1 ZNF296 NAV2 ULK4 ZER1 POLL RIC8A DENND5A DOCK6 TTC38 ARHGAP21 PITPNM2 SZT2 GEMIN5 ARHGAP35 MAP1S HELZ2 NUP188 UBE3C ULK2 SYMPK | 1.07e-10 | 1105 | 220 | 29 | 35748872 |
| Pubmed | IRF2BP2 SENP3 PSMC4 TUBGCP4 DIAPH1 MMS19 CLUH GPD2 PON2 PPP1R10 PPP2R5C NUP155 MAP1S PELP1 PRKAA1 LRRC1 NUP133 WDR41 SYMPK | 3.75e-09 | 560 | 220 | 19 | 35241646 | |
| Pubmed | MKKS RO60 DNAAF5 ERAL1 RIC8A CLEC16A ARHGAP21 IPO8 SZT2 CAMK2D CAMK2G ATG2B RICTOR NUP155 MAP1S NUP133 WDR41 UBE3C AURKB | 1.33e-08 | 606 | 220 | 19 | 36538041 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | QPCTL PSMC4 GFPT1 DNAAF5 FBN2 FAM120A PTPRM ERAL1 PRMT9 CLUH IPO8 ARHGAP10 PON2 IDE CNNM3 NUP155 FLAD1 PRKAA1 LRRC1 NUP133 PUS1 NUP188 UBE3C CDK2 | 1.64e-08 | 974 | 220 | 24 | 28675297 |
| Pubmed | CYLD RAPGEF5 TSC1 ADCY6 DENND4B KATNIP CLEC16A ARHGAP21 WHRN APPBP2 CAMK2A SYNE1 ARHGEF12 UBE3C ULK2 | 5.96e-08 | 407 | 220 | 15 | 12693553 | |
| Pubmed | PSMC4 TSC1 CBARP BIRC6 PTPRM GPD2 ARMT1 MYBBP1A DDX31 PDPR ARHGAP10 SMPD4 RICTOR IDE FAN1 CNNM3 PPP1R10 PPP2R5C NUP155 LRRC1 NUP133 PUS1 AURKB SYMPK | 6.56e-08 | 1049 | 220 | 24 | 27880917 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYO9A SPTB LINC02910 INTS3 F7 PLEKHM1 DNAAF5 FAM120A FAM120C KATNIP DENND5A DOCK6 CLEC16A ADGRD1 PITPNM2 RASA2 PCDHGB1 ARHGAP10 AAK1 PON2 MSH5 IDE ARHGAP35 LRRC8D LRCH3 LRRC1 VPS41 UBE3C ZRANB1 | 8.26e-08 | 1489 | 220 | 29 | 28611215 |
| Pubmed | INTS1 TSC1 BIRC6 REPIN1 GFPT1 NOD1 FAM106A RIC8A SZT2 CAMK2G KERA RICTOR CNNM3 LINS1 PPP2R5C PELP1 UPF2 LRRC20 VPS41 FIBP NUP188 TAF5L ULK2 ZRANB1 KAT14 HECA CDK2 | 1.01e-07 | 1327 | 220 | 27 | 32694731 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MKKS QPCTL CDK15 RIPK2 PSMC4 TSC1 RO60 MAST2 CFLAR DNAAF5 PI4KB PYGM MMS19 BCAR3 MNAT1 ARMT1 MYBBP1A CAMK2A CAMK2D PON2 SMPD4 CNNM3 NUP133 FIBP NUP188 CDK2 | 1.96e-07 | 1284 | 220 | 26 | 17353931 |
| Pubmed | NOL6 INTS1 BIRC6 GFPT1 FAM120A UTP20 FH CLUH MYBBP1A REXO4 DDX31 GEMIN5 NUP155 PELP1 HELZ2 NUP133 NUP188 SYMPK | 2.21e-07 | 653 | 220 | 18 | 22586326 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | INTS1 LRRC70 BIRC6 GFPT1 IGSF10 FAM120C DENND4B MAP3K9 UTP20 APPBP2 REXO4 ANK1 OR52L1 PARP14 RANBP3L TLR3 PITPNM3 NUP188 SYMPK | 2.74e-07 | 736 | 220 | 19 | 29676528 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOL6 PSMC4 RO60 MAST2 GFPT1 FAM120A ERAL1 DIAPH1 UTP20 FH CLUH MGAM2 GPD2 MYBBP1A REXO4 IPO8 SYNE1 GEMIN5 IDE NUP155 PELP1 NUP133 PUS1 NUP188 TAF5L UBE3C CDK2 | 4.12e-07 | 1425 | 220 | 27 | 30948266 |
| Pubmed | CYLD AHI1 USP45 ERCC5 SALL3 RAPGEF5 REPIN1 TAOK3 ERAL1 DIAPH1 MAP3K9 ARHGAP21 ARMT1 MYBBP1A RASA2 CAMK2D GEMIN5 RICTOR MSH5 PPP2R5C PRKAA1 NUP188 ULK2 | 4.68e-07 | 1084 | 220 | 23 | 11544199 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | QPCTL PSMC4 RO60 GFPT1 DNAAF5 UTP20 RIC8A MMS19 MYBBP1A HECTD3 CAMK2D RDH14 CNNM3 NUP155 PCSK6 NUP133 NUP188 HERPUD1 CDK2 AURKB SYMPK | 6.93e-07 | 942 | 220 | 21 | 31073040 |
| Pubmed | IRF2BP2 LRRC37A3 SENP3 NOL6 LRRC70 INTS3 GFPT1 PI4KB ARMT1 RASA2 HECTD3 CAMK2G PON2 IDE ABCC6 PITPNM3 IRAK3 | 7.72e-07 | 638 | 220 | 17 | 31182584 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | CDK15 MAST2 TAOK3 MAP3K9 HECTD3 CAMK2A CAMK2D CAMK2G PRKAA1 VPS41 IRAK3 CDK3 AURKB | 8.42e-07 | 372 | 220 | 13 | 22939624 |
| Pubmed | 8.45e-07 | 28 | 220 | 5 | 12471243 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 10381553 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 20007910 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 11889801 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 22419166 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 9.94e-07 | 4 | 220 | 3 | 17367784 | |
| Pubmed | SENP3 NOL6 TUBGCP4 INTS3 MAST2 ADCY6 TAOK3 FAM120A CARD6 DENND5A CLEC16A ARHGAP21 HECTD3 RICTOR NUP155 UPF2 PRKAA1 | 9.95e-07 | 650 | 220 | 17 | 38777146 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ERCC5 INTS1 RIPK2 TAOK3 MAP3K9 BCAR3 MNAT1 ARHGAP21 CAMK2D CAMK2G AAK1 MAP1S PRKAA1 NUP133 FIBP IRAK3 NUP188 CDK2 CDK3 AURKB | 1.60e-06 | 910 | 220 | 20 | 36736316 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A MYO9A SENP3 NOL6 PSMC4 TSC1 BIRC6 GFPT1 FAM120A ERAL1 DIAPH1 UTP20 RIC8A MMS19 MYBBP1A REXO4 RASA2 CAMK2D CAMK2G AAK1 GEMIN5 RICTOR NUP155 UPF2 NUP133 | 1.79e-06 | 1353 | 220 | 25 | 29467282 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | SETD1A SENP3 NOL6 INTS1 FAM120C MYBBP1A PARP14 PPP1R10 UPF2 PUS1 NUP188 SYMPK | 2.09e-06 | 341 | 220 | 12 | 32971831 |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 14722083 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 18218981 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 2.47e-06 | 5 | 220 | 3 | 16436603 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 11013247 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 19671701 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 21209221 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCN IRF2BP2 ERCC5 RREB1 INTS3 ADCY6 UTP20 CLUH CSTF2T MYBBP1A AAK1 GEMIN5 RICTOR ARHGAP35 MAP1S HELZ2 CDK2 SYMPK | 2.49e-06 | 774 | 220 | 18 | 15302935 |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 2.76e-06 | 183 | 220 | 9 | 31932471 | |
| Pubmed | MYO9A SPTB TSC1 FAM120A FAM120C FH ARHGAP21 AGAP2 GPD2 PITPNM2 MYBBP1A VWF CAMK2A CAMK2D SYNE1 CAMK2G AAK1 ARHGEF12 GEMIN5 ARHGAP35 LRCH3 MAP1S UPF2 PRKAA1 SLC4A10 | 4.78e-06 | 1431 | 220 | 25 | 37142655 | |
| Pubmed | CARD6 is a modulator of NF-kappa B activation by Nod1- and Cardiak-mediated pathways. | 4.92e-06 | 6 | 220 | 3 | 12775719 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 4.92e-06 | 6 | 220 | 3 | 18948074 | |
| Pubmed | Evaluation of Nod-like receptor (NLR) effector domain interactions. | 4.92e-06 | 6 | 220 | 3 | 19337385 | |
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 16120608 | ||
| Pubmed | Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. | 4.92e-06 | 6 | 220 | 3 | 11972023 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1A NOL6 GFPT1 MMS19 MYBBP1A DDX31 GEMIN5 RICTOR LRCH3 NUP155 PELP1 NUP133 NUP188 | 5.30e-06 | 440 | 220 | 13 | 34244565 |
| Pubmed | QPCTL INTS1 PSMC4 TUBGCP4 BIRC6 FAM120A MMS19 AGAP2 MYBBP1A CAMK2D CAMK2G GEMIN5 PARP14 LRRC8D CNNM3 NUP155 PELP1 HELZ2 NUP133 NUP188 HERPUD1 HECA | 5.75e-06 | 1168 | 220 | 22 | 19946888 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | SENP3 FAM120A UTP20 MMS19 MYBBP1A REXO4 PARP14 MAP1S PELP1 SYMPK | 7.39e-06 | 262 | 220 | 10 | 36880596 |
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 8.58e-06 | 7 | 220 | 3 | 9115241 | |
| Pubmed | 8.58e-06 | 7 | 220 | 3 | 34932950 | ||
| Pubmed | Addendum: defective Dock2 expression in a subset of ASC-deficient mouse lines. | 8.58e-06 | 7 | 220 | 3 | 22905357 | |
| Pubmed | CYLD RREB1 MAST2 REPIN1 ADCY6 FAT1 FBN2 FAM120A FAM120C DIAPH1 RIC8A MMS19 HECTD3 ARHGAP10 RICTOR PCSK6 FIBP NUP188 TAF5L KAT14 AURKB | 9.61e-06 | 1116 | 220 | 21 | 31753913 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PSMC4 TSC1 BIRC6 FAM120A ERAL1 MMS19 CLUH GPD2 MYBBP1A PDPR IPO8 SYNE1 ATG2B THUMPD1 SMPD4 IDE RMDN2 NUP155 UPF2 FLAD1 NUP133 PUS1 WDR41 NUP188 UBE3C | 1.02e-05 | 1496 | 220 | 25 | 32877691 |
| Pubmed | SETD1A SENP3 NOL6 INTS1 INTS3 BIRC6 FAM120A MYBBP1A PARP14 PPP1R10 PELP1 NUP133 AURKB | 1.05e-05 | 469 | 220 | 13 | 27634302 | |
| Pubmed | CYLD SENP3 NOL6 CBARP BIRC6 ARL6 FAT1 PI4KB CLEC16A ARHGAP21 MYBBP1A REXO4 RICTOR CNNM3 NUP155 ZBED6 WDR41 | 1.06e-05 | 777 | 220 | 17 | 35844135 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | AHI1 PSMC4 TUBGCP4 RREB1 ADCY6 ARL6 DNAAF5 PI4KB KATNIP POLL CLUH WHRN MYBBP1A IPO8 ARHGAP10 CAMK2A ATG2B AAK1 LRCH3 PPP1R10 PPP2R5C NUP133 AURKB | 1.24e-05 | 1321 | 220 | 23 | 27173435 |
| Pubmed | Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. | 1.37e-05 | 8 | 220 | 3 | 10329646 | |
| Pubmed | 1.37e-05 | 8 | 220 | 3 | 20668654 | ||
| Pubmed | 1.37e-05 | 8 | 220 | 3 | 11264466 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | INTS1 PSMC4 ADCY6 FAT1 PTPRM FH DOCK6 TMPPE GPD2 PDPR RDH14 SMPD4 LRRC8D TBC1D8 CNNM3 VPS41 SLC4A10 NUP188 UBE3C SYMPK | 1.54e-05 | 1061 | 220 | 20 | 33845483 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | PSMC4 TUBGCP4 F7 FAT1 FAM120A SERTAD1 CAMK2D LRCH3 ITPKC PPP2R5C SLC4A10 CDK2 CDK3 AURKB SYMPK | 1.57e-05 | 639 | 220 | 15 | 23443559 |
| Pubmed | Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3. | 2.04e-05 | 9 | 220 | 3 | 23148704 | |
| Pubmed | 2.04e-05 | 9 | 220 | 3 | 12660151 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SENP3 INTS1 PSMC4 TUBGCP4 INTS3 FAM120C ERAL1 DIAPH1 MYBBP1A NUP155 LRRC1 CDK3 AURKB SYMPK | 2.32e-05 | 582 | 220 | 14 | 20467437 |
| Pubmed | 2.90e-05 | 10 | 220 | 3 | 18261938 | ||
| Pubmed | 2.90e-05 | 10 | 220 | 3 | 19776387 | ||
| Pubmed | 2.90e-05 | 10 | 220 | 3 | 23064749 | ||
| Pubmed | 2.90e-05 | 10 | 220 | 3 | 28361052 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SENP3 NOL6 BIRC6 FAM120A UTP20 MYBBP1A REXO4 DDX31 IPO8 NUP155 PELP1 UPF2 NUP133 UBE3C ZRANB1 AURKB | 3.02e-05 | 759 | 220 | 16 | 35915203 |
| Pubmed | 3.97e-05 | 11 | 220 | 3 | 21491429 | ||
| Pubmed | 3.97e-05 | 11 | 220 | 3 | 17433728 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 28800131 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 28114344 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 22315414 | ||
| Pubmed | Mutational characteristics of ANK1 and SPTB genes in hereditary spherocytosis. | 3.98e-05 | 2 | 220 | 2 | 26830532 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 22219374 | ||
| Pubmed | Alterations of L-type calcium current and cardiac function in CaMKII{delta} knockout mice. | 3.98e-05 | 2 | 220 | 2 | 20538682 | |
| Pubmed | Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. | 3.98e-05 | 2 | 220 | 2 | 11427698 | |
| Pubmed | CaMKII mediates recruitment and activation of the deubiquitinase CYLD at the postsynaptic density. | 3.98e-05 | 2 | 220 | 2 | 24614225 | |
| Pubmed | CaMKII is essential for the function of the enteric nervous system. | 3.98e-05 | 2 | 220 | 2 | 22952977 | |
| Pubmed | Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress. | 3.98e-05 | 2 | 220 | 2 | 11175748 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 21252154 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 31619570 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 24746552 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 26567004 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 26834734 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 25124496 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 38341852 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 33238586 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 12083486 | ||
| Pubmed | Cognitive phenotypes in Alzheimer's disease and genetic variants in ACE and IDE. | 3.98e-05 | 2 | 220 | 2 | 21232820 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 38597448 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 36520365 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 17579072 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16581782 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 34301174 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 24958724 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 26755628 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 21498625 | ||
| Pubmed | Depletion of mTOR ameliorates CD4+ T cell pyroptosis by promoting autophagy activity in septic mice. | 3.98e-05 | 2 | 220 | 2 | 37738689 | |
| Pubmed | Predictive impact of common variations in DNA repair genes on clinical outcome of osteosarcoma. | 3.98e-05 | 2 | 220 | 2 | 23886164 | |
| Pubmed | Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis. | 3.98e-05 | 2 | 220 | 2 | 30158588 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 25193973 | ||
| Pubmed | K+-Driven Cl-/HCO3- Exchange Mediated by Slc4a8 and Slc4a10. | 3.98e-05 | 2 | 220 | 2 | 38674160 | |
| Pubmed | A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. | 3.98e-05 | 2 | 220 | 2 | 11172011 | |
| Interaction | COMTD1 interactions | INTS1 INTS3 DNAAF5 PRMT9 MMS19 IPO8 GEMIN5 TBC1D8 UPF2 LRRC1 NUP133 NUP188 ZRANB1 | 2.90e-07 | 200 | 218 | 13 | int:COMTD1 |
| Interaction | TOP3B interactions | MYCN SETD1A SPTB INTS1 LINC02910 ATG2A MAST2 BIRC6 REPIN1 ADCY7 PLEKHM1 FAT1 FAM120A ZNF296 FAM120C NAV2 ULK4 ZER1 POLL RIC8A MMS19 DENND5A DOCK6 TTC38 ARHGAP21 PITPNM2 SZT2 GEMIN5 ARHGAP35 MAP1S PELP1 UPF2 HELZ2 NUP188 UBE3C ULK2 SYMPK | 1.21e-06 | 1470 | 218 | 37 | int:TOP3B |
| Interaction | C9orf78 interactions | MYCN IRF2BP2 SENP3 PSMC4 TUBGCP4 DIAPH1 MMS19 CLUH GPD2 PON2 PPP1R10 PPP2R5C NUP155 MAP1S PELP1 PRKAA1 LRRC1 NUP133 WDR41 ZRANB1 SYMPK | 4.10e-06 | 620 | 218 | 21 | int:C9orf78 |
| Interaction | CAMK2D interactions | CYLD SETD1A TSC1 TSHR CLEC16A AGAP2 CAMK2A CAMK2D CAMK2G PON2 RICTOR ZRANB1 | 5.73e-06 | 222 | 218 | 12 | int:CAMK2D |
| Interaction | SPINK14 interactions | 2.19e-05 | 16 | 218 | 4 | int:SPINK14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 5.98e-05 | 139 | 220 | 6 | chr5p13 | |
| Cytoband | 5p13.1 | 8.40e-05 | 18 | 220 | 3 | 5p13.1 | |
| Cytoband | 4q31.23 | 4.73e-04 | 7 | 220 | 2 | 4q31.23 | |
| GeneFamily | SUMO specific peptidases|5FMC ribosome biogenesis complex | 7.90e-04 | 6 | 133 | 2 | 1301 | |
| GeneFamily | Phosphatidylinositol transfer proteins | 7.90e-04 | 6 | 133 | 2 | 1151 | |
| GeneFamily | NLR family | 7.95e-04 | 25 | 133 | 3 | 666 | |
| GeneFamily | Cyclin dependent kinases | 8.94e-04 | 26 | 133 | 3 | 496 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 1.37e-03 | 30 | 133 | 3 | 959 | |
| GeneFamily | Nucleoporins | 1.65e-03 | 32 | 133 | 3 | 1051 | |
| GeneFamily | Autophagy related | 1.81e-03 | 33 | 133 | 3 | 1022 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.33e-03 | 10 | 133 | 2 | 53 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 3.38e-03 | 12 | 133 | 2 | 573 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.21e-03 | 206 | 133 | 6 | 682 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | USP45 ERN1 RO60 CFLAR PTPRM HECTD3 SYNE1 ARHGAP35 NLRP3 CNNM3 PPP2R5C | 9.11e-07 | 198 | 218 | 11 | M6511 |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | USP45 INTS1 UBA7 PI4KB ZER1 SZT2 ATG2B CNNM3 HELZ2 NUP188 KAT14 | 1.01e-06 | 200 | 218 | 11 | M6208 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | PATL2 NOL6 INTS1 PSMC4 ATG2A INTS3 REPIN1 ADCY7 PLEKHM1 DNAAF5 UBA7 ZNF296 ERAL1 KATNIP MMS19 CLEC16A PDPR FBXW9 AAK1 CNNM3 HELZ2 WDR73 HERPUD1 | 2.19e-06 | 905 | 218 | 23 | M40865 |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | 6.41e-06 | 197 | 218 | 10 | M12824 | |
| Coexpression | GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN | USP18 RIPK2 CFLAR DENND4B GPD2 RASA2 PARP14 NLRP3 IRAK3 HERPUD1 | 7.32e-06 | 200 | 218 | 10 | M8654 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | MYCN SPTB ATG2A MAST2 ADCY6 CFLAR MAP3K9 DLEC1 FH DOCK6 TTC38 KIF25 OSGIN1 APPBP2 DDX31 CAMK2G AAK1 TERT ABCC6 ITPKC CHST4 CDK3 | 7.97e-06 | 909 | 218 | 22 | M41018 |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 2.73e-05 | 186 | 218 | 9 | M8175 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | 4.46e-05 | 198 | 218 | 9 | M6522 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN | 4.63e-05 | 199 | 218 | 9 | M7332 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN | 4.63e-05 | 199 | 218 | 9 | M7711 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 4.63e-05 | 199 | 218 | 9 | M6519 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN | 4.82e-05 | 200 | 218 | 9 | M8033 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN | 4.82e-05 | 200 | 218 | 9 | M6261 | |
| Coexpression | BILD_MYC_ONCOGENIC_SIGNATURE | 6.77e-05 | 209 | 218 | 9 | M2069 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-07 | 189 | 220 | 9 | 7dad62bd50c197838058e89abd0ee387de3e83cd | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-07 | 191 | 220 | 9 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.11e-07 | 200 | 220 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.40e-06 | 181 | 220 | 8 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.00e-06 | 185 | 220 | 8 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.47e-06 | 193 | 220 | 8 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.68e-06 | 194 | 220 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_CTL|URO / Disease, condition lineage and cell class | 6.59e-06 | 198 | 220 | 8 | c53405a8d082fbd10131a6ec88b69fdd835f2925 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.10e-06 | 200 | 220 | 8 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-05 | 159 | 220 | 7 | 235ed12053b337aca5abc2ce8727332b4ae3f8ae | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.63e-05 | 162 | 220 | 7 | fe546c2272a70bb5f08e6e097b9accdb891eda23 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.06e-05 | 168 | 220 | 7 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.40e-05 | 172 | 220 | 7 | a126dacd94939851de1403d30f0b63eaad48bfa1 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 174 | 220 | 7 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 177 | 220 | 7 | c2b8a3a149d70f77612759dea34df9e43953c566 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 177 | 220 | 7 | 384f841aa7b2d05815af7885e481f5affc55d897 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 177 | 220 | 7 | 0e9e44119653abfd270e602e5e477a15e774638f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-05 | 180 | 220 | 7 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.82e-05 | 185 | 220 | 7 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.82e-05 | 185 | 220 | 7 | 7d6954bb04368ec62b284ba6c3021a15fbdfdee6 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.52e-05 | 190 | 220 | 7 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.52e-05 | 190 | 220 | 7 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-05 | 190 | 220 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 4.67e-05 | 191 | 220 | 7 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 4.67e-05 | 191 | 220 | 7 | db7b8f8826bf19d6eeee14319570a9e6e99ab2cb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.83e-05 | 192 | 220 | 7 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.83e-05 | 192 | 220 | 7 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.99e-05 | 193 | 220 | 7 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.99e-05 | 193 | 220 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.99e-05 | 193 | 220 | 7 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.99e-05 | 193 | 220 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.99e-05 | 193 | 220 | 7 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.99e-05 | 193 | 220 | 7 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.99e-05 | 193 | 220 | 7 | 21a117cceb562439ca3fe129aad8cac5f5728b1f | |
| ToppCell | PBMC-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 5.16e-05 | 194 | 220 | 7 | b903e23eb75733ca516770727097fe74a9f8c1d1 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 194 | 220 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 194 | 220 | 7 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 194 | 220 | 7 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 194 | 220 | 7 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 5.33e-05 | 195 | 220 | 7 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.50e-05 | 196 | 220 | 7 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 5.68e-05 | 197 | 220 | 7 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.68e-05 | 197 | 220 | 7 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.05e-05 | 199 | 220 | 7 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | 6.05e-05 | 199 | 220 | 7 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 | |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | 6.05e-05 | 199 | 220 | 7 | d6c299312c747fb1b7c53644c53efc03a5fffe85 | |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | 6.05e-05 | 199 | 220 | 7 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 | |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | 6.05e-05 | 199 | 220 | 7 | 33ac6d77099076df01299be429f4ba96f2f34cc1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.25e-05 | 200 | 220 | 7 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.25e-05 | 200 | 220 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-05 | 200 | 220 | 7 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.25e-05 | 200 | 220 | 7 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Sigmoid-ILC|Sigmoid / Region, Cell class and subclass | 6.25e-05 | 200 | 220 | 7 | dfb06821f1019833f5d81f9c93808219b5fef407 | |
| ToppCell | Sigmoid-(3)_ILC|Sigmoid / shred on region, Cell_type, and subtype | 6.25e-05 | 200 | 220 | 7 | a7326c43987a5eb4f4f5b48c4252cf4870432e5d | |
| ToppCell | Sigmoid-(3)_ILC-(30)_ILC|Sigmoid / shred on region, Cell_type, and subtype | 6.25e-05 | 200 | 220 | 7 | c39de94623383da7b2b260eb016ddaa5da7f4350 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-05 | 200 | 220 | 7 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.25e-05 | 200 | 220 | 7 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | (3)_ILC|World / shred on Cell_type and subtype | 6.25e-05 | 200 | 220 | 7 | 03554b3f323785b1e0b48fa32de0d92065dd798e | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Sigmoid-ILC-ILC|Sigmoid / Region, Cell class and subclass | 6.25e-05 | 200 | 220 | 7 | 4ac1e6d7f358003e2448eb69e545772cd261c55f | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 220 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.25e-05 | 200 | 220 | 7 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.25e-05 | 200 | 220 | 7 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | (30)_ILC|World / shred on Cell_type and subtype | 7.08e-05 | 204 | 220 | 7 | bd9fbd278c05e396463704d711b60d47699e3c09 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 151 | 220 | 6 | ea62e92ccb984f44559b434f35c1c4450767c8f1 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.13e-04 | 153 | 220 | 6 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-04 | 153 | 220 | 6 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.35e-04 | 158 | 220 | 6 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-MAIT|Bac-SEP / Disease, Lineage and Cell Type | 1.40e-04 | 159 | 220 | 6 | e043c65f3febdfa7f75a67702e92fcdebe144a00 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-04 | 159 | 220 | 6 | af137688e06a97ff97bb7def54f0dd164d155b11 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 160 | 220 | 6 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 160 | 220 | 6 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-04 | 161 | 220 | 6 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.60e-04 | 163 | 220 | 6 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-04 | 163 | 220 | 6 | e4077e587895c85bc806be05ff5d451088e39468 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-04 | 163 | 220 | 6 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 1.65e-04 | 164 | 220 | 6 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-MAIT|ICU-SEP / Disease, Lineage and Cell Type | 1.65e-04 | 164 | 220 | 6 | db863a44fc0dad5518c47fdbf64ea21d6f36f089 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-04 | 164 | 220 | 6 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 166 | 220 | 6 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | COPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.77e-04 | 166 | 220 | 6 | e2cad1db536d5ad5a34c337c19b5e7d1a2851552 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-04 | 168 | 220 | 6 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| Drug | ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A | AHI1 MAST2 ADCY6 CFLAR TTC38 CSTF2T IPO8 AAK1 ARHGAP35 SLC4A3 LRRC1 | 2.51e-06 | 194 | 215 | 11 | 1205_UP |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A | ADCY6 CFLAR FH CSTF2T ARHGAP10 ARHGEF12 ERN2 PPP2R5C PCSK6 PRKAA1 CDK3 | 2.91e-06 | 197 | 215 | 11 | 7458_DN |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | ADCY7 GFPT1 CFLAR MAP3K9 ZER1 OSGIN1 ERN2 HERPUD1 CDK3 SYMPK | 9.53e-06 | 182 | 215 | 10 | 998_UP |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | 1.21e-05 | 187 | 215 | 10 | 6190_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.39e-05 | 190 | 215 | 10 | 1306_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | 1.59e-05 | 193 | 215 | 10 | 4488_DN | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A | FAM120C MAP3K9 POLL FH TTC38 GPD2 ARHGEF12 SLC4A3 LINS1 ULK2 | 1.66e-05 | 194 | 215 | 10 | 1805_UP |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; PC3; HT_HG-U133A | CYLD RAPGEF5 SPTB DIAPH1 MAP3K9 FH CLEC16A ARHGAP10 ERN2 CDK3 | 1.82e-05 | 196 | 215 | 10 | 1801_UP |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; PC3; HT_HG-U133A | 1.82e-05 | 196 | 215 | 10 | 3760_DN | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A | 1.90e-05 | 197 | 215 | 10 | 7292_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; PC3; HT_HG-U133A | RAPGEF5 MAST2 MAP3K9 ZER1 TTC38 GPD2 DDX31 ARHGAP10 PUS1 CDK3 | 1.90e-05 | 197 | 215 | 10 | 4658_DN |
| Disease | Glycogen Storage Disease Type V | 5.14e-05 | 2 | 212 | 2 | C0017924 | |
| Disease | Ciliopathies | 1.47e-04 | 110 | 212 | 6 | C4277690 | |
| Disease | anemia (implicated_via_orthology) | 1.56e-04 | 15 | 212 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.91e-04 | 16 | 212 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | esophageal carcinoma, gastric carcinoma | 2.31e-04 | 17 | 212 | 3 | EFO_0000178, EFO_0002916 | |
| Disease | Immunoglobulin A deficiency (disorder) | 3.05e-04 | 4 | 212 | 2 | C0162538 | |
| Disease | head and neck carcinoma, lung cancer | 3.05e-04 | 4 | 212 | 2 | MONDO_0002038, MONDO_0008903 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 3.25e-04 | 19 | 212 | 3 | DOID:1168 (biomarker_via_orthology) | |
| Disease | hereditary spherocytosis (is_implicated_in) | 5.07e-04 | 5 | 212 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 5.07e-04 | 5 | 212 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 5.07e-04 | 5 | 212 | 2 | C0221409 | |
| Disease | Usher Syndrome, Type II | 5.07e-04 | 5 | 212 | 2 | C1568249 | |
| Disease | airway responsiveness measurement | 6.62e-04 | 24 | 212 | 3 | EFO_0006897 | |
| Disease | Disorder of eye | 8.94e-04 | 212 | 212 | 7 | C0015397 | |
| Disease | Hereditary retinal dystrophy | 1.05e-03 | 7 | 212 | 2 | C0154860 | |
| Disease | common variable immunodeficiency | 1.05e-03 | 7 | 212 | 2 | MONDO_0015517 | |
| Disease | Glioblastoma Multiforme | 1.26e-03 | 111 | 212 | 5 | C1621958 | |
| Disease | Galloway Mowat syndrome | 1.40e-03 | 8 | 212 | 2 | C0795949 | |
| Disease | Hereditary spherocytosis | 1.40e-03 | 8 | 212 | 2 | C0037889 | |
| Disease | cholesterol to total lipids in very large HDL percentage | 1.42e-03 | 31 | 212 | 3 | EFO_0022243 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.56e-03 | 32 | 212 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | age at onset, coronary stenosis | 1.79e-03 | 9 | 212 | 2 | EFO_0004847, MONDO_0006715 | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.79e-03 | 9 | 212 | 2 | DOID:988 (is_implicated_in) | |
| Disease | Cardiovascular Diseases | 2.19e-03 | 36 | 212 | 3 | C0007222 | |
| Disease | age at menarche, spine bone mineral density | 2.23e-03 | 10 | 212 | 2 | EFO_0004703, EFO_0007701 | |
| Disease | hip bone mineral density, age at menarche | 2.23e-03 | 10 | 212 | 2 | EFO_0004703, EFO_0007702 | |
| Disease | Congenital myasthenic syndrome | 2.23e-03 | 10 | 212 | 2 | cv:C0751882 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 2.23e-03 | 10 | 212 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | coagulation factor XA measurement | 2.71e-03 | 11 | 212 | 2 | EFO_0020266 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.93e-03 | 82 | 212 | 4 | EFO_0008535 | |
| Disease | multiple system atrophy | 2.97e-03 | 40 | 212 | 3 | EFO_1001050 | |
| Disease | Myeloproliferative disease | 3.23e-03 | 12 | 212 | 2 | C0027022 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 3.33e-03 | 85 | 212 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.37e-03 | 139 | 212 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | intermediate coronary syndrome (is_marker_for) | 3.80e-03 | 13 | 212 | 2 | DOID:8805 (is_marker_for) | |
| Disease | Gastric Adenocarcinoma | 4.16e-03 | 45 | 212 | 3 | C0278701 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.16e-03 | 45 | 212 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | obesity (is_implicated_in) | 4.25e-03 | 91 | 212 | 4 | DOID:9970 (is_implicated_in) | |
| Disease | nodular sclerosis Hodgkin lymphoma | 4.42e-03 | 14 | 212 | 2 | EFO_0004708 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 4.42e-03 | 14 | 212 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | atrial fibrillation (is_implicated_in) | 4.42e-03 | 14 | 212 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | thalamus volume change measurement | 4.42e-03 | 14 | 212 | 2 | EFO_0021496 | |
| Disease | T wave morphology measurement | 4.42e-03 | 14 | 212 | 2 | EFO_0008398 | |
| Disease | anemia (is_implicated_in) | 4.42e-03 | 14 | 212 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | red blood cell density measurement | IRF2BP2 MYO9A RREB1 MAST2 KLHL30 ULK4 ANK1 RICTOR TERT ABCC6 PCSK6 PUS1 TAF5L ZRANB1 | 4.77e-03 | 880 | 212 | 14 | EFO_0007978 |
| Disease | Paroxysmal atrial fibrillation | 5.49e-03 | 156 | 212 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 5.49e-03 | 156 | 212 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 5.49e-03 | 156 | 212 | 5 | C2585653 | |
| Disease | QT interval | NOL6 MAST2 CLUH ARHGAP21 ARHGAP10 CAMK2D PON2 SLC4A3 CNNM3 RNF207 | 5.50e-03 | 534 | 212 | 10 | EFO_0004682 |
| Disease | neutrophil count, basophil count | 5.77e-03 | 224 | 212 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 5.77e-03 | 16 | 212 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | coronary artery disease (is_implicated_in) | 5.94e-03 | 100 | 212 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | Atrial Fibrillation | 6.10e-03 | 160 | 212 | 5 | C0004238 | |
| Disease | age at menopause | 6.41e-03 | 302 | 212 | 7 | EFO_0004704 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 6.51e-03 | 17 | 212 | 2 | C2936862 | |
| Disease | diabetic retinopathy (is_marker_for) | 6.93e-03 | 54 | 212 | 3 | DOID:8947 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEKLHILHKVANSPL | 266 | A8MVM7 | |
| ARLTHLHLPPLKIVT | 166 | Q8N350 | |
| PQILTKVIDTLHRHK | 26 | Q9H993 | |
| SVLRTLLLKHSHPND | 416 | P48751 | |
| LLHTKSLDIEIPKHI | 231 | Q6P2P2 | |
| TIHLPAAVLLKEIHI | 3211 | Q9NR09 | |
| AAVLLKEIHIQPHLA | 3216 | Q9NR09 | |
| PEHLHKIGLLDRVTN | 431 | P12821 | |
| PIIHRDLKVENILLH | 171 | Q2M2I8 | |
| PLITVHLKHRLTRKQ | 481 | Q6QNK2 | |
| LEIHPNGKRLLIHTK | 806 | Q8N157 | |
| ITLPHGHQLRLDIIE | 586 | O75815 | |
| RLLHNILPKDVAAHF | 946 | O43306 | |
| AVHHNNLDIVKLLLP | 576 | P16157 | |
| LNHPLHISDRVILIS | 36 | Q4KMX7 | |
| EEHKIFLLKVLLPLH | 241 | Q13362 | |
| LRSPLHLAAELAHVV | 1091 | Q99490 | |
| LNILLNIVHPTLSHD | 51 | Q8N268 | |
| IGIITHILPEDHLLL | 361 | Q92624 | |
| HILPEDHLLLASSKR | 366 | Q92624 | |
| TLLNHPDIKHRRIPI | 111 | Q9H0F7 | |
| RLLLENVLPAHVAAH | 846 | P51828 | |
| AEPHFLSILQHLLLV | 406 | O60610 | |
| RKAVETHLLRNPHLV | 76 | O15519 | |
| PHKNVKEFLVTLRLH | 1056 | Q2TAZ0 | |
| DSIHLLLSPRQVHLL | 316 | Q96BY7 | |
| ELLKSRPAHLAVFLH | 376 | Q9NZN5 | |
| LKHSILSLPIHVQAA | 66 | P56880 | |
| HLRKLDHISESVPVL | 321 | Q9UGP5 | |
| VLPLVRLLLHHDKLV | 361 | Q15283 | |
| RLLLHHDKLVPFATA | 366 | Q15283 | |
| EKRLHRLNLLQSHPQ | 296 | Q9NXS2 | |
| LNHIVEKRVLAHLAP | 461 | Q68E01 | |
| KTVALPDHQTLSHRL | 641 | Q96DU7 | |
| DLLPKQEKRHVLHLV | 71 | Q15011 | |
| RAAHLPELLSLVHLD | 211 | Q0D2K2 | |
| ATQIVDLHIIKLPHL | 366 | Q96NI6 | |
| DLHIIKLPHLLNSTN | 371 | Q96NI6 | |
| RVNAIHFLVHKLPEK | 491 | A1A4S6 | |
| RPLDRELQHEHSLKI | 881 | Q14517 | |
| IITLSNLHRHALKPF | 2446 | Q14517 | |
| RLIPESSGKIHQHIL | 231 | Q8WUM0 | |
| VLILSSNFLRHVPKH | 221 | Q7Z5L7 | |
| KHQQLHSRPVLTLLA | 301 | Q5XUX1 | |
| SALLSHLLVTHPILK | 61 | Q9NPJ1 | |
| HLLVTHPILKILTAS | 66 | Q9NPJ1 | |
| LHKLILNHNPLTTVE | 966 | O60309 | |
| LQHPVLLSRLVVLDH | 211 | Q86YD5 | |
| KLVSLPEEIGHLRHL | 161 | Q96II8 | |
| LHERANLLEIAPHLS | 141 | P43304 | |
| LELLIASRIHLKLHF | 256 | Q8NG48 | |
| ELRNLLLDPASHKLL | 101 | Q66K74 | |
| QHISLAPIHKLEEAL | 231 | P51948 | |
| LHKLILNHNPLTTVE | 966 | A6NM11 | |
| LHKLILNHNPLTTVE | 966 | A6NMS7 | |
| RKILKAPLDHINLHV | 1651 | Q2M2H8 | |
| CRKLAVAHPLLLLRH | 1866 | Q8N201 | |
| LAQTSEKLIPHLHKL | 656 | Q6ZRS4 | |
| RLDLSELLTHIPRHK | 346 | Q9UBI9 | |
| IKERAAHPLLHLRSE | 156 | Q8NHJ6 | |
| ENRLKDHHLVIPSVL | 96 | Q96T76 | |
| HLKSKDPVQLRLEHL | 51 | O60303 | |
| LHIVHRDLKPGNILI | 631 | Q76MJ5 | |
| RHPAAIVDDLHAKVL | 1651 | Q2LD37 | |
| QHLLVKTSRPAHLKA | 446 | P29122 | |
| LEALQRPTLLHLIHG | 116 | P55157 | |
| LLLEKPLDREHQSSH | 191 | Q9Y5G3 | |
| IISPKKVAELHHLLN | 156 | Q8NCN5 | |
| PHLLTQVKAILQSHI | 666 | Q6ZU69 | |
| PHLLTQVKAILQSHI | 396 | Q63HN1 | |
| PKLQLLSQIRSHLHR | 611 | Q9H8E8 | |
| KQKRHHLELSLLEDP | 176 | O75616 | |
| KRLIPHQVVTHLLAL | 611 | Q9H6R4 | |
| SHPHIQLLKSNRELL | 16 | Q9Y239 | |
| HKARSSHLLQVLPAE | 346 | Q0VF49 | |
| RQPLHLHSLHKVLLL | 111 | Q9HCC8 | |
| HKVLLDDDNLLPLLH | 401 | Q9UGJ1 | |
| EHPLASLKVRAHQLV | 261 | Q9NZB2 | |
| SELEVLLLFHHPNIL | 211 | Q9Y616 | |
| LHRLPSEVSALQHLK | 86 | Q8TCA0 | |
| NFLKLLISELHLRVH | 1191 | Q9BZ72 | |
| PRELKHIFHVRSLHL | 726 | Q9H8H2 | |
| KEETHRRLHDLVLPL | 541 | Q8IZL8 | |
| ALITTILHLLNHPKT | 226 | Q6R327 | |
| HPRVLKPLSSLIHLQ | 341 | Q7Z2Q7 | |
| HVLDVAGNRLLHLPL | 361 | Q9BTT6 | |
| GLDLLPELHQRTIHL | 41 | Q5SRI9 | |
| QHLLLLVGIHLLKSP | 596 | Q9BQG0 | |
| FHKLRPVDQLRHLLV | 511 | O75694 | |
| PTEEHVLVVRLLLKH | 361 | Q9NXE4 | |
| VLVVRLLLKHLHAFA | 366 | Q9NXE4 | |
| SKLHLRVVTLIEHPF | 511 | Q8TCU5 | |
| LEDPLELHKIRIHVL | 101 | Q9H158 | |
| SLLHLKTVKHELLPS | 151 | Q15165 | |
| HHSIKQLQLSPRLLE | 211 | Q460N5 | |
| AVTILLAITHHLPLL | 386 | C9JE40 | |
| VHPRHSTLTLAIKVL | 796 | Q96QU1 | |
| HRVIHRDLKPQNLLI | 121 | Q00526 | |
| RLVHLEGNQLTKLHP | 156 | Q6WRI0 | |
| KLHKIFLHQDLPLLV | 481 | Q9BX69 | |
| SHHVLDKLVRLVIRP | 776 | Q96HP0 | |
| LHRDLKPQNLLISHL | 221 | Q96Q40 | |
| SLNIVHRDLKPHNIL | 681 | O75460 | |
| VIHLKNNREHLPLIG | 391 | Q8NCQ5 | |
| IEVHEVLLPGLQKLH | 201 | P07954 | |
| PLLTAEQNHLLHLVL | 346 | P23610 | |
| LLLCDLILHFNHPIK | 36 | C9J3I9 | |
| LLSLRPLNIDSPHHK | 101 | P26998 | |
| EHPLASLKVRAHQLV | 336 | Q9NX05 | |
| VNHTPTHLLKEIILV | 176 | Q6IS24 | |
| LRLAKIDHTAIHPHL | 641 | Q6IQ26 | |
| HQKHRDLALVPDELL | 1781 | Q6P0Q8 | |
| AVLTEHKLLVHSLRP | 416 | O75064 | |
| HKLLVHSLRPDLLTS | 421 | O75064 | |
| IPITRSLQKALHHLS | 341 | Q8IYD9 | |
| IPQLLSRLHIEALLH | 716 | P14735 | |
| IALKILHRKIHVTPL | 186 | Q9H0L4 | |
| QLLPVLLLHAEDHAT | 381 | Q86Y56 | |
| HLGSKEHILELRPAI | 2811 | P35556 | |
| HRVLHRDLKPQNLLI | 121 | P24941 | |
| LNILFHHILRVEPLL | 686 | Q9NQC7 | |
| HHILRVEPLLKIRSA | 691 | Q9NQC7 | |
| AVHSEEPLLHVALLK | 186 | Q9BYK8 | |
| ALLHLFHAAVQRKLP | 411 | Q8NFF5 | |
| IDSELLRKHHLISPE | 196 | Q9Y238 | |
| KQHLLTHRLKELPSQ | 1021 | Q9BXA9 | |
| RPKTVRDTLLALHQH | 301 | Q7Z5L9 | |
| RLLKHPNIVRLHDSI | 66 | Q13555 | |
| LHDEAIVPIIHRDLK | 256 | P80192 | |
| RLLKHPNIVRLHDSI | 66 | Q13557 | |
| LESLRELRHLKILHV | 581 | Q7L1W4 | |
| AIHPHPLLQRKLTEA | 46 | Q9UJX0 | |
| RAHLLLPQLKENDTH | 81 | P28827 | |
| LHPAIRVADLLQHIT | 876 | P28827 | |
| GNKTIIVLSHLDPHL | 41 | P59922 | |
| HQLDVAIPLHLKSQL | 1136 | Q9HAU5 | |
| LLLHTLERIQLPHNP | 796 | O15397 | |
| APKALAVLLVHAHEI | 96 | Q8NGH7 | |
| LHRLLGHIKNVPLIL | 306 | O43196 | |
| LERLLHAPPKLLHQL | 66 | O43427 | |
| RPVALEKLQHLLDHP | 351 | Q96P20 | |
| LSLPRHLKVVGQIEH | 156 | Q9NQ35 | |
| LALNLHQHLKRLEPT | 711 | Q9Y2M0 | |
| RLLPLKFVKISIHDH | 121 | Q8TC56 | |
| RILVGHALHNDLKVL | 321 | Q9GZR2 | |
| PLLKAVTHKHIISEL | 91 | Q9Y4G2 | |
| LTLHIHLDVQPAKRT | 191 | O75529 | |
| RLVLILEHDTPIPKH | 581 | Q5T011 | |
| LLHLRKLRHDVVQTA | 696 | O75691 | |
| SHLATLLPTLQVHLV | 281 | Q6ZRF8 | |
| ILGHILHRLAEKSLP | 531 | Q9C093 | |
| LLIAEQEHSSKLRHP | 291 | Q8IWB6 | |
| RELLKPNASVALHKH | 121 | P43686 | |
| LALLRLEPHHVILEG | 81 | Q96D59 | |
| EHLIQPLHRDGKLSL | 366 | Q8NF91 | |
| VLKRVTIHLEDLAPH | 4831 | Q8NF91 | |
| VRSEHKLSTDHIPIL | 211 | Q06210 | |
| TRILVTHALHILPQA | 806 | O95255 | |
| ILEKINSHLPSHIRI | 166 | Q9Y606 | |
| LHPVLLTIGLHKEEA | 521 | Q587J7 | |
| HDIALLRLHQPVVLT | 301 | P08709 | |
| SQDLRHVIIPLLHTV | 66 | Q5UE93 | |
| ENPHLLTLFHRLCKL | 51 | P28715 | |
| KVPRISAHLQHLHLD | 276 | O60938 | |
| PLVIILDNLHHVSSL | 2221 | Q8IVL1 | |
| TPEKILEHLLNDLHL | 76 | Q92565 | |
| HLFKEHLDIAIKLLP | 286 | Q96LZ7 | |
| HALIHRDIKAGNILL | 141 | Q9H2K8 | |
| HLILTVKDVGRLPHA | 351 | Q9P202 | |
| RHIHIPLLVKPLFNL | 256 | Q9HBH5 | |
| HVPLRKVHLFTLIQL | 946 | Q2Y0W8 | |
| LLKHPNIVRLHDSIS | 66 | Q9UQM7 | |
| LQLRAKHPTLVHADS | 181 | Q9UIL4 | |
| LKLHHSLQQSEPDLR | 51 | Q9UHV2 | |
| RLISELSLLNHKLPA | 351 | Q9UBF8 | |
| KARIHPFHILIALET | 316 | P10155 | |
| NHLVHLPLTLILVNK | 691 | Q9NRY4 | |
| LHKTHRLKESVAPVL | 321 | Q9NPQ8 | |
| EEVEILLHPRTRKHL | 121 | O15047 | |
| LVLHLRAHSAAKRPI | 131 | Q9BWE0 | |
| IQNLKLFRHPHIIKL | 76 | Q13131 | |
| ILNVHVPRLHLKFIA | 71 | Q8N4F0 | |
| LKDPSLNLHIVHLVR | 191 | Q8NCG5 | |
| LLSQVFLIIHHAPLV | 316 | Q2KHT3 | |
| ISEKVLLHLLKHPSV | 516 | Q8NE01 | |
| LLHLLKHPSVNQEVR | 521 | Q8NE01 | |
| HVRHVRDLLKSLDPS | 131 | O75153 | |
| IEIQAHLHHPNILRL | 126 | Q96GD4 | |
| STLILHLRIHNGEKL | 371 | Q5HYK9 | |
| FNKELLLIPIHLEVH | 451 | Q9H4L4 | |
| LTTLQEPHDKHLLDR | 61 | Q92574 | |
| SELILHQRLHTGVKP | 276 | Q8N9K5 | |
| VIVQLHKLRHLDISR | 241 | Q7Z7L7 | |
| RKIIFVITHHLLKDP | 811 | O15455 | |
| QTLLKHHKIHTRERP | 486 | Q6P9A3 | |
| SAVPAVLILHLKRFH | 676 | Q70EL2 | |
| VRLPGLHNSLVKLKH | 446 | P04275 | |
| SELILKRCLPIHQQH | 316 | P04198 | |
| HLLETLLPRHLQIIY | 391 | P11217 | |
| TVRHKSLDTALLQPH | 261 | P41226 | |
| LRHNALVHKQLPRDA | 251 | Q92766 | |
| PLLHHDLKTQNILLD | 141 | O43353 | |
| VKHSKHVIRPAILQL | 116 | Q86VV4 | |
| ALLARLKQVHANHPV | 386 | O95759 | |
| RILEHIQILALSEHK | 171 | Q92670 | |
| RHVPLRKVHLFTIIQ | 976 | Q6U841 | |
| QTLIKDRTALPLHHL | 271 | A6NCN8 | |
| PAKQLLLHICHDLTL | 1196 | Q8TEQ6 | |
| HKHDPALPRLAIQLL | 861 | Q5SRE5 | |
| LAFNALIHKHRPDLI | 206 | P11277 | |
| VIIKTLISAHPIIRH | 311 | Q8N841 | |
| NIGTHVDPILLIHRI | 716 | P49754 | |
| PQRSCKTHVLLLVLH | 121 | Q9BZ71 | |
| LKLHLLSVLKHPASL | 301 | Q92797 | |
| SLLLLHLRLHTGEKP | 381 | Q6ZMY9 | |
| ILHSKGIIHRDLKPQ | 121 | Q8IYT8 | |
| VLPVARKHSRDHILL | 316 | Q5R3I4 | |
| QVLPLIHHLLLSLQK | 711 | P86452 | |
| QVLKLTHLPQTLTIH | 241 | Q3LFD5 | |
| DLTIPKHRHLLQAKN | 381 | Q9H7P9 | |
| QVLKLTHLPQTLTIH | 241 | Q9UMW8 | |
| ILLLIPSISHEAHKT | 11 | Q6UY13 | |
| RHSRPLIFINHKKLI | 96 | Q96SR6 | |
| LKTLKRLIHDLPEHH | 1256 | Q5T5U3 | |
| LTLQHLPLTVDHLKQ | 96 | Q96QC0 | |
| LLVTPHLTHAKTFLR | 871 | O14746 | |
| LLVLKAHHDIVRFLV | 36 | Q9HAD4 | |
| RTLGIEPEKLVHHIL | 131 | Q9NXG2 | |
| IFDLKHVPHTRLLVT | 86 | Q6P4I2 | |
| IALLLHQRTHLEEKP | 331 | Q14929 | |
| FLPLVDSERKLLHVH | 616 | Q9UGI0 | |
| PDLKKRIRVHLLNAH | 746 | Q15386 | |
| LHSPLFQLLIQHLRI | 506 | Q96C45 | |
| IRKRLHKDIPHHSVI | 326 | Q5TIE3 | |
| LRATLDKHLRQKHPE | 456 | Q8WUU4 | |
| TLKLIETHLRTIPSH | 56 | P16473 | |
| DHTIILLAHQPLAAK | 361 | Q6ZT21 | |
| LQRFIKILDSVLHHL | 411 | Q5T447 | |
| LLCEALKPHRALHTL | 971 | Q86W25 | |
| ILIAINRHGVLLIHP | 2026 | Q6PIF6 | |
| NRHGVLLIHPKTKDL | 2031 | Q6PIF6 | |
| ALPKHLLEVNSLKHL | 851 | B2RTY4 |